Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Real-time Diagnosis of Diminutive Colorectal Polyps Using AI (COMET-OPTICAL)

29 de abril de 2022 atualizado por: Maastricht University Medical Center

Real Time Computer-aided Diagnosis (CADx) of Diminutive Colorectal Polyps Using Artificial Intelligence

Correct endoscopic prediction of the histopathology and differentiation between benign, pre-malignant, and malignant colorectal polyps (optical diagnosis) remains difficult. Artificial intelligence has great potential in image analysis in gastrointestinal endoscopy. Aim of this study is to investigate the real-time diagnostic performance of AI4CRP for the classification of diminutive colorectal polyps, and to compare it with the real-time diagnostic performance of commercially available CADx systems.

Visão geral do estudo

Status

Recrutamento

Condições

Intervenção / Tratamento

Descrição detalhada

Correct endoscopic prediction of the histopathology and differentiation between benign, pre-malignant, and malignant colorectal polyps (optical diagnosis) remains difficult. Despite additional training, even experienced endoscopists continue to fail meeting international thresholds set for safe implementation of treatment strategies based on optical diagnosis.

Multiple machine learning techniques - computer-aided diagnosis (CADx) systems - have been developed for applications in medical imaging within colonoscopy and can improve endoscopic classification of colorectal polyps.

Aim of this study is to explore the feasibility of the workflow using AI4CRP (a CNN based CADx system) real-time in the endoscopy suite, and to investigate the real-time diagnostic performance of AI4CRP for the diagnosis of diminutive (<5mm) colorectal polyps. Secondary, the real-time performance of commercially available CADx systems will be investigated and compared with AI4CRP performance.

Tipo de estudo

Observacional

Inscrição (Antecipado)

105

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

  • Holanda
    • Limburg
    • Noord-Brabant
      • Eindhoven, Noord-Brabant, Holanda, 5623 EJ
        • Concluído
        • Catharina Ziekenhuis Eindhoven

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Patient receiving a colonoscopy because of regular care will be considered eligible for inclusion if at least one diminutive colorectal polyp is encountered during the colonoscopy. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases.

Descrição

Inclusion Criteria:

  • Age >18 years;
  • Patients with at least one colorectal polyps encountered during colonoscopy;
  • Patients referred for a colonoscopy by the Dutch bowel cancer screening program, patients undergoing a colonoscopy for endoscopic surveillance, or patients undergoing a colonoscopy because of complaints;
  • Written informed consent.

Exclusion Criteria:

  • Patients with prior history of inflammatory bowel diseases (IBD) or polyposis syndromes;
  • Patients with inadequate bowel preparations after adequate washing, suctioning, and cleaning manoeuvres have been performed by the endoscopist;
  • Patients undergoing an emergency colonoscopy;
  • Written objection in the patient file for participation in scientific research.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
Gastroenterology patients

Patient receiving a colonoscopy because of regular care will be considered eligible for inclusion if at least one diminutive colorectal polyp is encountered during the colonoscopy. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases.

Colonoscopies will be executed using Fujifilm endoscopy systems (Fujifilm® Corporation, Tokyo, Japan), using Pentax endoscopy systems (Pentax Medical®, Hamburg, Germany), and using Olympus endoscopy systems (Olympus®, Tokyo, Japan).
Dispositivo: Computer-aided diagnosis (CADx) systems
  • AI4CRP (artificial intelligence for colorectal polyps), a CNN based computer-aided diagnosis system for diagnosis of colorectal polyps (COMET-OPTICAL research group);
  • CAD EYE, a computer-aided diagnosis system for diagnosis of colorectal polyps (Fujifilm® Corporation, Tokyo, Japan).
Outros nomes:
  • AI4CRP, artificial intelligence for colorectal polyps (COMET-OPTICAL research group)
  • CAD EYE (Fujifilm® Corporation, Tokyo, Japan)

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Technical feasibility of real-time use of AI4CRP.
Prazo: 6 months
The technical feasibility of real-time use of AI4CRP in the endoscopy suite regarding a proper reception of the video output from the local endoscopy processor towards AI4CRP (in high definition quality, without any delays in time).
6 months
User interface feasibility of real-time use of AI4CRP.
Prazo: 6 months
The user interface feasibility of real-time use of AI4CRP in the endoscopy suite regarding a correct alignment of the user interface of AI4CRP with the video output from the local endoscopy system (resizing image pixels and anonymization).
6 months
The diagnostic accuracy of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Prazo: 1 year
The real-time diagnostic accuracy of AI4CRP per image modality (HDWL, BLI, LCI, i-scan). Diagnostic accuracy defined as the percentage of correctly optically diagnosed colorectal polyps.
1 year
The sensitivity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Prazo: 1 year
The real-time sensitivity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year
The specificity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Prazo: 1 year
The real-time specificity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year
The negative predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Prazo: 1 year
The real-time negative predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year
The positive predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Prazo: 1 year
The real-time positive predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year
The Area Under ROC Curve (AUC) of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Prazo: 1 year
The real-time Area Under ROC Curve (AUC) of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
The diagnostic accuracy of AI4CRP per polyp.
Prazo: 1 year
The real-time diagnostic accuracy of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The sensitivity of AI4CRP per polyp.
Prazo: 1 year
The real-time sensitivity of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The specificity of AI4CRP per polyp.
Prazo: 1 year
The real-time specificity of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The negative predictive value of AI4CRP per polyp.
Prazo: 1 year
The real-time negative predictive value of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The positive predictive value of AI4CRP per polyp.
Prazo: 1 year
The real-time positive predictive value of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The Area Under ROC Curve (AUC) of AI4CRP per polyp.
Prazo: 1 year
The real-time Area Under ROC Curve (AUC) of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The diagnostic accuracy of CAD EYE in BLI mode, per polyp.
Prazo: 1 year
The real-time diagnostic accuracy of CAD EYE in BLI mode, per polyp.
1 year
The sensitivity of CAD EYE in BLI mode, per polyp.
Prazo: 1 year
The real-time sensitivity of CAD EYE in BLI mode, per polyp.
1 year
The specificity of CAD EYE in BLI mode, per polyp.
Prazo: 1 year
The real-time specificity of CAD EYE in BLI mode, per polyp.
1 year
The negative predictive value of CAD EYE in BLI mode, per polyp.
Prazo: 1 year
The real-time negative predictive value of CAD EYE in BLI mode, per polyp.
1 year
The positive predictive value of CAD EYE in BLI mode, per polyp.
Prazo: 1 year
The real-time positive predictive value of CAD EYE in BLI mode, per polyp.
1 year
The Area Under ROC Curve (AUC) of CAD EYE in BLI mode, per polyp.
Prazo: 1 year
The real-time Area Under ROC Curve (AUC) of CAD EYE in BLI mode, per polyp.
1 year
The diagnostic accuracy of AI4CRP per patient.
Prazo: 1 year
The real-time diagnostic accuracy of AI4CRP per patient (in case of multiple polyps per patient).
1 year
The diagnostic accuracy of CAD EYE per patient.
Prazo: 1 year
The real-time diagnostic accuracy of CAD EYE per patient (in case of multiple polyps per patient).
1 year
The localization score of AI4CRP.
Prazo: 1 year
The localization score of AI4CRP regarding the number of images in which the heatmap produced by AI4CRP pointed out the area of interest (scale: correct, incorrect, or partly correct area of interest).
1 year
The difference in diagnostic accuracy of endoscopists per polyp before and after AI.
Prazo: 1 year
The difference in real-time diagnostic accuracy of endoscopists per polyp before and after AI.
1 year
The difference in sensitivity of endoscopists per polyp before and after AI.
Prazo: 1 year
The difference in real-time sensitivity of endoscopists per polyp before and after AI.
1 year
The difference in specificity of endoscopists per polyp before and after AI.
Prazo: 1 year
The difference in real-time specificity of endoscopists per polyp before and after AI.
1 year
The difference in negative predictive value of endoscopists per polyp before and after AI.
Prazo: 1 year
The difference in real-time negative predictive value of endoscopists per polyp before and after AI.
1 year
The difference in positive predictive value of endoscopists per polyp before and after AI.
Prazo: 1 year
The difference in real-time positive predictive value of endoscopists per polyp before and after AI.
1 year
The agreement in surveillance interval based on optical diagnosis and histopathology.
Prazo: 1 year
The agreement in surveillance interval based on optical diagnosis of diminutive colorectal polyps and histopathology of small and large colorectal polyps, compared to the surveillance interval based on histopathology of all colorectal polyps (diminutive, small, and large).
1 year

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Maastricht University Medical Center

Colaboradores

Catharina Ziekenhuis Eindhoven
Eindhoven University of Technology

Investigadores

  • Investigador principal: Erik Schoon, Prof Dr MD, Maastricht Universitair Medisch Centrum

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

20 de agosto de 2021

Conclusão Primária (Antecipado)

1 de setembro de 2022

Conclusão do estudo (Antecipado)

1 de dezembro de 2022

Datas de inscrição no estudo

Enviado pela primeira vez

31 de março de 2022

Enviado pela primeira vez que atendeu aos critérios de CQ

21 de abril de 2022

Primeira postagem (Real)

27 de abril de 2022

Atualizações de registro de estudo

Última Atualização Postada (Real)

5 de maio de 2022

Última atualização enviada que atendeu aos critérios de controle de qualidade

29 de abril de 2022

Última verificação

1 de abril de 2022

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • METC2021-3036

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Descrição do plano IPD

A data sharing plan is not yet decided on.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever